Helix BioPharma Corp. (Helix; TSX,
FSE: "HBP") today announced that it has received a milestone payment of
USD$125,000 from Lumera Corporation (Lumera; NASDAQ: "LMRA") under the terms
of the license agreement signed between the parties approximately one year
ago.
